Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rotarix + Tritanrix HepB
- Development stage
- Unknown
- Lead developer
- GSK
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Oral, Intramuscular
01
Overview
Rotarix + Tritanrix HepB is a combination immunization regimen involving two separate vaccines administered concomitantly in infants. - **Rotarix** is a live attenuated oral vaccine containing human rotavirus strain RIX4414, developed to prevent rotavirus gastroenteritis. It works by stimulating an immune response against rotavirus infection through exposure to the weakened virus[4][8][9]. - **Tritanrix HepB** is a combination injectable vaccine that contains diphtheria toxoid, tetanus toxoid, whole-cell pertussis (DTPw), and hepatitis B surface antigen (HepB). It induces immunity against diphtheria, tetanus, pertussis (whooping cough), and hepatitis B by presenting these antigens to the immune system[2]. The co-administration of these vaccines allows for simultaneous protection against multiple serious childhood diseases without reducing immunogenicity or safety of either component[1][9]. Both are primarily indicated for routine infant immunization.
- Other names
- RIX4414 + DTPw-HepB-Hib
02
Targets
HBsAg (Hepatitis B surface antigen)VP4 (Rotavirus VP4)NSP4 (Rotavirus non-structural glycoprotein 4)VP7 (Rotavirus VP7)TT (Tetanus toxoid)VP6 (Rotavirus capsid protein VP6)
Beyond the preview
Go deeper on Rotarix + Tritanrix HepB.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rotarix + Tritanrix HepB.